XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/national/2020/02/28/biogen-sangamo-ink-neuro-deal-for-new-gene-regulation-therapies/60%Monthly2020-02-28 22:38
https://xconomy.com/national/2020/02/28/bio-roundup-covid-19-trials-esperions-approvals-nash-news-more/60%Monthly2020-02-28 15:53
https://xconomy.com/national/2020/02/28/passage-bios-ipo-raises-216m-to-fund-gene-therapy-studies/60%Monthly2020-02-28 14:13
https://xconomy.com/new-york/2020/02/27/biohavens-migraine-pill-is-the-latest-cgrp-drug-to-win-the-fdas-ok/60%Monthly2020-02-28 19:59
https://xconomy.com/boston/2020/02/27/xenotherapeutics-names-michael-yaremchuk-as-its-chief-medical-officer/60%Monthly2020-02-27 21:11
https://xconomy.com/san-diego/2020/02/27/halozyme-therapeutics-appoints-sutrovaxs-elaine-sun-as-new-cfo/60%Monthly2020-02-27 20:31
https://xconomy.com/national/2020/02/27/gilead-moderna-candidates-ramp-up-coronavirus-drug-vaccine-testing/60%Monthly2020-02-27 17:38
https://xconomy.com/europe/2020/02/27/nouscoms-udier-named-ceo-delaite-appointed-chief-medical-officer/60%Monthly2020-02-27 15:42
https://xconomy.com/san-francisco/2020/02/27/adverum-promotes-angela-thedinga-to-chief-technology-officer/60%Monthly2020-02-27 15:38
https://xconomy.com/detroit-ann-arbor/2020/02/26/esperions-combo-pill-for-lowering-cholesterol-levels-wins-fda-nod/60%Monthly2020-02-26 23:51
https://xconomy.com/san-diego/2020/02/26/takeda-bases-pvp-biologics-buyout-on-promising-early-celiac-drug-data/60%Monthly2020-02-26 20:46
https://xconomy.com/san-francisco/2020/02/26/with-foamix-merger-weeks-away-menlo-itching-drug-fails-a-phase-2-test/60%Monthly2020-02-26 17:45
https://xconomy.com/boston/2020/02/25/skyhawks-terry-connolly-takes-on-new-role-as-chief-operating-officer/60%Monthly2020-02-25 19:04
https://xconomy.com/seattle/2020/02/25/aurinia-taps-abeonas-max-colao-as-chief-commercial-officer/60%Monthly2020-02-25 18:54
https://xconomy.com/boston/2020/02/25/bicycle-therapeutics-lands-30m-from-genentech-in-new-cancer-rd-pact/60%Monthly2020-02-25 17:30
https://xconomy.com/europe/2020/02/25/uk-reveals-plans-for-dynamic-post-brexit-regulatory-system/60%Monthly2020-02-27 15:46
https://xconomy.com/detroit-ann-arbor/2020/02/24/esperions-fda-approved-cholesterol-drug-priced-even-lower-than-expected/60%Monthly2020-02-25 00:59
https://xconomy.com/san-francisco/2020/02/24/ngm-bios-nash-drug-shows-promise-shares-rise-on-early-phase-2-data/60%Monthly2020-02-24 23:10
https://xconomy.com/boston/2020/02/24/invetx-fetches-15m-to-develop-biologic-drugs-for-mans-best-friend/60%Monthly2020-02-24 05:21
https://xconomy.com/national/2020/02/23/lundbecks-alder-bio-bet-pays-off-with-fda-approval-of-migraine-drug/60%Monthly2020-02-24 17:38
https://xconomy.com/national/2020/02/21/bio-roundup-agile-approval-coronavirus-collabs-spruces-88m-more/60%Monthly2020-02-21 14:39
https://xconomy.com/seattle/2020/02/20/seagen-adds-five-prime-therapeutics-antibodies-in-licensing-deal/60%Monthly2020-02-20 22:36
https://xconomy.com/san-diego/2020/02/20/turning-point-taps-effectors-reich-as-its-chief-scientific-officer/60%Monthly2020-02-20 20:47
https://xconomy.com/san-francisco/2020/02/20/spruce-bio-raises-88m-for-clinical-tests-of-rare-endocrine-disease-drug/60%Monthly2020-02-20 17:33
https://xconomy.com/boston/2020/02/19/enclear-therapies-nets-10m-to-test-neuro-disease-dialysis-device/60%Monthly2020-02-19 23:30
https://xconomy.com/national/2020/02/19/teva-drug-fails-to-beat-placebo-in-pediatric-tourette-patient-trials/60%Monthly2020-02-19 23:19
https://xconomy.com/national/2020/02/19/endo-names-blaise-coleman-successor-to-retiring-ceo-paul-campanelli/60%Monthly2020-02-20 18:15
https://xconomy.com/national/2020/02/19/pfizer-veteran-clavelli-appointed-optinose-chief-commercial-officer/60%Monthly2020-02-19 22:26
https://xconomy.com/boston/2020/02/19/xcelerating-life-sciences-boston-will-explore-biopharmas-future-in-digital-health/60%Monthly2020-02-19 20:15
https://xconomy.com/boston/2020/02/19/restorbio-pins-strategic-alternatives-pitch-to-parkinsons-promise/60%Monthly2020-02-19 18:45
https://xconomy.com/san-francisco/2020/02/18/five-prime-bristol-pancreatic-cancer-drug-combo-fails-phase-2-test/60%Monthly2020-02-20 19:49
https://xconomy.com/texas/2020/02/18/shattuck-labs-promotes-schreiber-to-ceo-succeeding-hornblower/60%Monthly2020-02-19 02:44
https://xconomy.com/national/2020/02/18/adaptimmune-taps-abcams-gavin-wood-for-chief-financial-officer-role/60%Monthly2020-02-18 23:15
https://xconomy.com/boston/2020/02/18/xcelerating-life-sciences-boston/60%Monthly2020-04-02 16:26
https://xconomy.com/boston/2020/02/18/imara-reveals-ipos-plan-as-sickle-cell-drug-advances-in-the-clinic/60%Monthly2020-03-04 19:42
https://xconomy.com/national/2020/02/18/new-meds-set-to-reshape-us-cns-and-oncology-markets/60%Monthly2020-02-20 18:37
https://xconomy.com/new-york/2020/02/14/agile-therapeutics-wins-fda-nod-for-twirla-contraceptive-patch/60%Monthly2020-02-15 02:27
https://xconomy.com/boston/2020/02/14/voyager-therapeutics-chief-operating-officer-matthew-ottmer-resigns/60%Monthly2020-02-14 23:21
https://xconomy.com/new-york/2020/02/14/immmunomedics-taps-medco-veteran-loretta-itri-as-chief-medical-officer/60%Monthly2020-02-14 19:08
https://xconomy.com/national/2020/02/14/bio-roundup-goodbye-belviq-logicbio-on-hold-revolutions-ipo-more/60%Monthly2020-02-14 15:58
https://xconomy.com/national/2020/02/13/eisai-pulls-weight-loss-drug-from-market-after-fda-flags-cancer-risks/60%Monthly2020-02-14 00:21
https://xconomy.com/san-francisco/2020/02/13/xcelerating-life-sciences-san-francisco/60%Monthly2020-04-02 16:26
https://xconomy.com/boston/2020/02/13/anika-therapeutics-appoints-cheryl-blanchard-interim-ceo/60%Monthly2020-02-13 18:20
https://xconomy.com/boston/2020/02/13/palleon-pharma-promotes-li-peng-to-chief-scientific-officer/60%Monthly2020-02-13 18:13
https://xconomy.com/san-francisco/2020/02/13/pioneering-women-in-personalized-medicine/60%Monthly2020-02-13 14:47
https://xconomy.com/san-francisco/2020/02/12/revolution-medicines-ipo-reels-in-238m-to-take-on-ras-in-cancer/60%Monthly2020-02-13 12:30
https://xconomy.com/san-diego/2020/02/12/ionis-pharmas-joseph-baroldi-joins-avidity-as-chief-operating-officer/60%Monthly2020-02-12 19:26
https://xconomy.com/detroit-ann-arbor/2020/02/12/millendo-picks-poxels-arbet-engels-for-chief-medical-officer-post/60%Monthly2020-02-12 19:18
https://xconomy.com/san-diego/2020/02/12/ligands-icagen-deal-brings-neuro-cf-assets-plus-partnering-potential/60%Monthly2020-02-12 19:40
https://xconomy.com/national/2020/02/12/crispr-car-t-consolidation-top-advanced-therapy-milestones-of-2019/60%Monthly2020-02-12 08:15
https://xconomy.com/san-francisco/2020/02/11/encoded-therapeutics-adds-rico-moorhead-to-c-suite/60%Monthly2020-02-11 22:48
https://xconomy.com/san-diego/2020/02/11/pfizer-veteran-abraham-joins-vividion-as-chief-scientific-officer/60%Monthly2020-02-11 21:34
https://xconomy.com/boston/2020/02/11/lyndra-taps-paciras-richard-stanton-for-chief-medical-officer-role/60%Monthly2020-02-11 21:28
https://xconomy.com/national/2020/02/11/two-big-pharma-alliances-end-in-nixed-deals-heres-what-happened/60%Monthly2020-02-11 20:35
https://xconomy.com/boston/2020/02/10/fda-clinical-hold-stops-logicbios-gene-editing-study-before-it-starts/60%Monthly2020-02-11 15:07
https://xconomy.com/boston/2020/02/10/wave-life-sciences-stumble-in-duchenne-leads-to-22-staff-layoff/60%Monthly2020-02-10 21:46
https://xconomy.com/new-york/2020/02/10/biohaven-drug-fails-anxiety-study-data-in-ocd-and-more-still-to-come/60%Monthly2020-02-10 19:06
https://xconomy.com/national/2020/02/10/eli-lilly-roche-drugs-fail-to-move-needle-in-genetically-driven-alzheimers/60%Monthly2020-02-10 23:57
https://xconomy.com/boston/2020/02/07/takedas-peng-lu-joins-pharvaris-as-chief-medical-officer/60%Monthly2020-02-07 22:51
https://xconomy.com/national/2020/02/07/complexa-appoints-elisabeth-leiderman-chief-business-officer/60%Monthly2020-02-07 22:46
https://xconomy.com/national/2020/02/07/bio-roundup-potus-on-prices-a16zs-fund-aimmunes-approval-more/60%Monthly2020-02-07 15:58
https://xconomy.com/national/2020/02/06/myriad-genetics-exec-capone-resigns-riggsbee-named-interim-ceo/60%Monthly2020-02-07 12:52
https://xconomy.com/new-york/2020/02/06/ichnos-sciences-appoints-gabriela-gruia-as-chief-development-officer/60%Monthly2020-02-07 00:48
https://xconomy.com/europe/2020/02/06/novartiss-wotling-to-join-dbv-as-chief-technical-operations-officer/60%Monthly2020-02-06 23:47
https://xconomy.com/raleigh-durham/2020/02/06/aerami-therapeutics-appoints-timm-crowder-chief-operating-officer/60%Monthly2020-02-06 23:42
https://xconomy.com/san-francisco/2020/02/06/sonoma-bio-launches-with-40m-to-take-cell-therapy-beyond-cancer/60%Monthly2020-02-07 13:32
https://xconomy.com/san-diego/2020/02/06/scripps-researchs-calibr-to-test-switchable-car-t-in-clinical-trial/60%Monthly2020-02-06 22:25
https://xconomy.com/new-york/2020/02/06/xcelerating-life-sciences-new-york/60%Monthly2020-02-19 14:17
https://xconomy.com/new-york/2020/02/06/xcelerating-life-sciences-philadelphia/60%Monthly2020-04-02 16:26
https://xconomy.com/national/2020/02/06/early-bird-sale-ending-for-san-diegos-xcelerating-life-sciences-conference/60%Monthly2020-02-06 19:11
https://xconomy.com/boston/2020/02/06/beam-therapeutics-ipo-raises-180m-after-nearly-doubling-shares-offered/60%Monthly2020-02-06 10:28
https://xconomy.com/san-francisco/2020/02/06/coda-bio-acquires-drug-candidates-to-pair-with-engineered-receptors/60%Monthly2020-02-06 06:26
https://xconomy.com/san-francisco/2020/02/05/aimmune-gets-200m-from-nestle-licenses-food-allergy-drug-candidate/60%Monthly2020-02-05 21:01
https://xconomy.com/new-york/2020/02/05/merck-charts-an-rd-focused-course-starting-with-a-6-5b-spinoff/60%Monthly2020-02-05 20:03
https://xconomy.com/national/2020/02/04/titan-medicals-cash-crunch-stalls-plans-to-get-surgical-robot-to-fda/60%Monthly2020-02-05 01:13
https://xconomy.com/san-francisco/2020/02/04/vertily-santen-see-opthalmology-opportunity-via-new-joint-venture/60%Monthly2020-02-05 17:42
https://xconomy.com/boston/2020/02/04/amylyx-pharmaceuticals-names-jeffrey-trigilio-chief-financial-officer/60%Monthly2020-02-04 18:17
https://xconomy.com/san-diego/2020/02/04/epirium-bio-names-biomarins-somaratne-its-chief-medical-officer/60%Monthly2020-02-04 18:33
https://xconomy.com/national/2020/02/04/750m-fund-looks-to-software-sector-to-drive-future-of-biotech/60%Monthly2020-02-04 17:23
https://xconomy.com/san-francisco/2020/02/04/portola-picks-adamas-pharmas-patni-for-chief-medical-officer-role/60%Monthly2020-02-04 15:03
https://xconomy.com/san-francisco/2020/02/04/biomarins-spiegelman-steps-down-mueller-steps-up-as-acting-cfo/60%Monthly2020-02-04 14:53
https://xconomy.com/new-york/2020/02/04/bristol-myers-biomotiv-pact-leads-to-a-new-fibrosis-focused-startup/60%Monthly2020-02-04 15:07
https://xconomy.com/new-york/2020/02/03/passage-bio-plans-ipo-as-three-gene-therapies-approach-the-clinic/60%Monthly2020-02-04 04:17
https://xconomy.com/new-york/2020/02/03/insmed-drug-for-rare-pulmonary-disorder-meets-phase-2-goals/60%Monthly2020-02-03 20:45
https://xconomy.com/san-francisco/2020/02/03/cytomx-appoints-alison-hannah-senior-vp-and-chief-medical-officer/60%Monthly2020-02-03 17:57
https://xconomy.com/boston/2020/02/03/boston-pharmacueuticals-picks-nibrs-basson-for-chief-medical-officer/60%Monthly2020-02-03 17:56
https://xconomy.com/national/2020/02/03/united-therapeutics-drug-flunks-small-cell-lung-cancer-clinical-trial/60%Monthly2020-02-03 17:55
https://xconomy.com/new-york/2020/02/03/discovery-labs-converts-ex-gsk-king-of-prussia-site-into-rd-colony/60%Monthly2020-01-31 20:39
https://xconomy.com/san-francisco/2020/01/31/aimmune-awarded-first-fda-approval-for-a-peanut-allergy-therapy/60%Monthly2020-02-05 20:56